Literature DB >> 1531013

Kinins mediate the antiproliferative effect of ramipril in rat carotid artery.

R D Farhy1, K L Ho, O A Carretero, A G Scicli.   

Abstract

Angiotensin-converting enzyme (ACE) inhibitors have been shown to inhibit neointimal proliferation in response to endothelial injury in the rat carotid artery. Since ACE inhibitors block degradation of kinins, our objective in this study was to determine whether kinins mediate the antiproliferative effect of the ACE inhibitor ramipril. Endothelial denudation was achieved in the left carotid artery of male Sprague-Dawley rats using a balloon catheter. The rats were divided into four groups: a) vehicle (saline); b) DuP 753 10 mg/kg/day; c) ramipril 5 mg/kg/day; and d) ramipril 5 mg/kg/day plus Hoe 140 70 micrograms/kg/day. Ramipril markedly reduced neointimal proliferation compared to control (vehicle) (p less than 0.05) and DuP 753-treated groups (p less than 0.05). When ramipril was given together with Hoe 140 its effect was significantly blunted (p less than 0.05). These results show that kinins are important mediators in the antiproliferative effect of ACE inhibitors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1531013     DOI: 10.1016/s0006-291x(05)80142-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

Review 1.  The role of kinins in the antihypertensive and cardioprotective effects of ACE inhibitors.

Authors:  G Bönner
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 2.  Is there a link between the circulating renin-angiotensin system and coronary disease? A sceptical view.

Authors:  J D Swales
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

Review 3.  Serum-derived growth factor is thrombin?

Authors:  S M Schwartz
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

Review 4.  Molecular aspects of kallikrein and kininogen in the maturing kidney.

Authors:  S S el-Dahr; S Dipp
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

5.  Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus.

Authors:  G O'Driscoll; D Green; J Rankin; K Stanton; R Taylor
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

Review 6.  [The renin-angiotensin system in cardiovascular diseases].

Authors:  C Unterberg; H Kreuzer; A B Buchwald
Journal:  Med Klin (Munich)       Date:  1998-07-15

7.  Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertension.

Authors:  M C Fournié-Zaluski; W Gonzalez; S Turcaud; I Pham; B P Roques; J B Michel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

8.  Balloon angioplasty enhances the expression of angiotensin II AT1 receptors in neointima of rat aorta.

Authors:  M Viswanathan; C Strömberg; A Seltzer; J M Saavedra
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

9.  Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats.

Authors:  W Linz; J Schaper; G Wiemer; U Albus; B A Schölkens
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

10.  Vascular smooth-muscle cells contain AT1 angiotensin receptors coupled to phospholipase D activation.

Authors:  E J Freeman; E A Tallant
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.